Ischemia-modified albumin levels in patients with acute decompensated heart failure treated with dobutamine or levosimendan: IMA-HF study

Creative Commons License

ÇAVUŞOĞLU Y., Korkmaz S., DEMİRTAŞ S., Gencer E., Sasmaz H., MUTLU F., ...More

ANATOLIAN JOURNAL OF CARDIOLOGY, vol.15, no.8, pp.611-617, 2015 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 15 Issue: 8
  • Publication Date: 2015
  • Doi Number: 10.5152/akd.2015.6156
  • Journal Name: ANATOLIAN JOURNAL OF CARDIOLOGY
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus, TR DİZİN (ULAKBİM)
  • Page Numbers: pp.611-617
  • Keywords: ischemia modified albumin, heart failure, acute, PERCUTANEOUS CORONARY INTERVENTION, TRANSIENT MYOCARDIAL-ISCHEMIA, OXIDATIVE STRESS, COBALT BINDING, FAILING MYOCARDIUM, MARKER, ANGIOPLASTY, MECHANISMS, EFFICIENCY, DIAGNOSIS
  • Eskisehir Osmangazi University Affiliated: Yes

Abstract

Objective: Ischemia-modified albumin (IMA) is a sensitive biomarker of myocardial ischemia. However, data on IMA levels in acute heart failure (HF) are still lacking. In this study, we aimed to evaluate serum IMA levels in acute decompensated HF and the effects of dobutamine and levosimendan treatments on IMA levels.